News & Events
NEWS & EVENTS
We have now included our 200th participant in the EFFECT trial!
 READ MORE
Thursday (28th of October), our PREFERABLE colleague Anouk Hiensch successfully defended her thesis entitled 'Stepping stones to implement exercise as integral part of cancer care'.
 READ MORE
We finally met in person again during our 6th PREFERABLE Consortium Meeting in San Sebastian.
 READ MORE
16 September 2021
We are now halfway through recruiting patients for the EFFECT study! This week, the 175th participant agreed to participate in the study. As a result, we have reached the EU-milestone. A big thanks to all participants and staff, who are all highly committed to the project.
 READ MORE
Due to the Corona pandemic, Poland only started recruitment in March. They already recruited the 10th participant by the end of August. Keep up the good work! In the meanwhile, all sites are up and running and we hope to be halfway through recruitment very soon.
 READ MORE
Because training centers were closed in Germany, the Heidelberg University Hospital developed a live-remote exercise intervention for participants of the EFFECT trial. Patients successfully follow the study intervention from their living rooms. They train as hard as in-person and enjoy the interaction with the trainer and the other participants.
 READ MORE
The team of Onkologikoa in San Sebastian, Spain, had the honor of including the 100th patient in the EFFECT trial. In addition, the first few patients have been included in Poland, which means that all countries are now recruiting.
 READ MORE
We just completed our 5th PREFERABLE consortium meeting. Great to work as a team with very motivated people. It is also encouraging that recruitment is going well under the current circumstances for both the EFFECT and PERSPECTIVE study.
 READ MORE
After a year of lockdowns and slow recruitment due to COVID-19 restrictions, we are very glad to announce that almost all sites are now recruiting for the EFFECT trial. In addition to recruitment in the Netherlands, Germany, Spain and Sweden, recruitment has now also started at an additional site in Germany (Cologne) and in Australia. And last but not least, Poland is expected to start very soon as well. To date 82 participants, of the 350 to be included, have started in the trial worldwide.
 READ MORE
21 December 2020
We are very happy to announce that patient recruitment for the EFFECT trial is progressing! Most sites were able to take measures to deal with the COVID-19 related restrictions and recruitment has been restarted. Off course, challenges remain but we are grateful that we can offer a place to most women now who are willing to join.
 READ MORE
Due to the COVID-19 pandemic, the patient recruitment for the EFFECT trial has been put on hold. All patients who were already included stopped exercising at a physiotherapy centre and will continue when they are allowed to. In the meantime, patients will perform home-based exercise.
 READ MORE
This time, the consortium meeting took place at the Medical University of Gdańsk in Poland.
 READ MORE
The consortium met at the German Sport University Cologne to prepare the EFFECT and PERSPECTIVE studies.
 READ MORE
PREFERABLE researchers Dr. Anne May (UMCU) and Prof. Dr. Karen Steindorf (DKFZ) have been invited by consortium member EUROPA DONNA – The European Breast Cancer Coalition to present at their 2nd MBC advocacy conference in Milan, Italy.
 READ MORE
PREFERABLE’s consortium members and advisors attended the 66th annual meeting of the American College of Sports Medicine (ACSM) in Orlando, Florida, USA. ACSM’s annual meeting brings together science and practice with leading experts and latest research on sports medicine and exercise oncology.
 READ MORE
The official launch of the PREFERABLE project took place on 10th and 11th January 2019. All project partners met in the University Medical Center Utrecht, NL, that is coordinator of the project.
 READ MORE
As the coordinator of the project UMC Utrecht attended the H2020 Coordinator’s Day in Brussels. All 10 coordinators from 5 countries who received funding within the H2020 call ‘Novel patient-centred approaches for survivorship, palliation and/or end-of-life care’ met at the European Commission to present and discuss their projects during a scientific meeting.
 READ MORE
TWITTER

We have included the 200th participant in our EFFECT study! We would like to thank all participating centers for their effort. Recruitment is ongoing, so patients can still sign-up. More information on https://h2020preferable.eu @ABCGlobalAll @europadonna @EUScienceInnov #H2020 #mBC

Congratulations to our PREFERABLE colleague ⁦@AnoukHiensch⁩ for successfully defending her thesis ⁦@UMCUtrecht⁩ ⁦@UtrechtUni⁩. https://youtu.be/-910e7Dc_jY

#BreastCancerAwareness month ends in a few days, but we can all continue to help raise awareness for those living with metastatic or advanced #BreastCancer. Hear more from @ABCGlobalAll ‘s Dr. Cardoso & #TBCT: https://youtu.be/Gff8Bmeod78

👉Fatigue, pain & vomiting are just some of the unpleasant side effects of metastatic #breastcancer (MBC).

💡Find out how #EUfunded @PREFERABLE_MBC project uses exercise interventions to reduce cancer-related fatigue & improve patients quality of life! ➡️http://europa.eu/!gPJ3Ty

At the age of 78, our oldest participant joined the training group this week. It's never too late to start training 💪
#PREFERABLE #breastcancer #metastaticbreastcancer

Load More...